# Safety and Efficacy Study in Acute Ischaemic Stroke

> **NCT00144014** · PHASE2 · COMPLETED · sponsor: **Vernalis (R&D) Ltd** · enrollment: 49 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** V10153

## Key facts

- **NCT ID:** NCT00144014
- **Lead sponsor:** Vernalis (R&D) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-11
- **Final completion:** 2009-03
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144014, "Safety and Efficacy Study in Acute Ischaemic Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00144014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*